Table 2. Release Kinetics Including the Kinetic Model Used in the Data Fitting, the Kinetics Constant of Release, the Total Release Time, and the Total Drug Releasea.
| drug |
||||||
|---|---|---|---|---|---|---|
| AAS |
IBU |
|||||
| material | kinetic modelb | k (mg·g–1·h–1/2) | release time (days) and delivered drug (%) | kinetic modelb | k (mg·g–1·h–1) or (mg·g–1·h–1/2) | release time (days) and delivered drug (%) |
| MIL-100 | H | 81.2 | 1 (99 ± 1%) | H | 53.2 | 4 (100 ± 2%) |
| UiO-66 | H | 94.7 | 1 (96 ± 2%) | H | 29.2 | 7 (81 ± 6%) |
| MIL-127 | H | 2.64 | 6 (61 ± 4%) | 0 | 5.04 | 4 (92 ± 5%) |
a
Comparison of the results obtained in this study in the delivery of IBU and AAS.
b
H = Higuchi model; 0 = zero-order kinetics.